The themes Envista is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Graded A or B and worth $2B or more: A first, then the largest.
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
各项收入占比是对six months ended July 3, 2026的估算,并非来自已提交报告的数字。
Dental implant systems and related products
Systems for replacing missing teeth, including implants, guided-surgery products, bone-regeneration materials, and tooth restorations. Brands include Nobel Biocare, Alpha-Bio Tec, and Implant Direct.
DTX Studio software
Software that helps dental professionals review patient images and plan implant procedures and restorations.
Orthodontic brackets, wires, and related products
Products orthodontists use to move teeth, including brackets, wires, tubes, bands, retainers, and laboratory products. Brands include Ormco and Damon.
Spark clear aligners
Removable clear trays used to straighten teeth, with software for planning and reviewing treatment.
Dental imaging equipment
Dental X-ray systems, digital sensors, and intraoral scanners used to capture images of patients’ teeth and mouths. Brands include DEXIS and i-CAT.
Dental consumables and infection-prevention products
Materials and tools used in routine dental care, including restorative materials, root-canal products, burs, bonding agents, cements, and surface disinfectants. Brands include Kerr, Sybron Endo, and Metrex.
Envista makes products used to diagnose, treat, and prevent problems with teeth and gums, and to improve smiles. It sells to general dentists, dental specialists, orthodontists, dental laboratories, and dental groups, directly and through distributors. Its products range from dental imaging and treatment-planning software to tooth-replacement systems, braces, restorative materials, root-canal products, and disinfectants.
基于 Envista Holdings Corporation 自己向美国证券交易委员会(SEC)提交的申报文件。数字如实呈报,每股历史已重述到今天的股数口径。 这是对一门生意的描述——不是投资建议,也不是买卖任何证券的推荐。
NVST · NYSE · Healthcare · Medical Instruments and Supplies
US$24.50-0.6%11月13日 收盘
数据截至2026年10月2日,来自2026年11月4日提交的10-Q
Envista makes dental implants, orthodontic braces and clear aligners, dental imaging equipment and software, and materials used in dental care.
Just reported
From Envista's results release of 2026年11月4日; its quarterly report has since been filed.
Actual
US$691.5M
+3.2% y/y
-5.3% q/q
Guided
—
No guide given
Actual
US$3.11
Guided
—
No guide given
EPS, adjusted: US$0.40
Actual
US$515.2M
Guided
—
No guide given
Full year 2026
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
Grade B+
价格下方的色带显示每个日期的评级,仅依据当时已公开的文件计算。
显示 Envista Holdings Corporation 评级历史 28 个季度中的 2 个。 其余 26 个可回溯到 2020年2月。